The Latest Breaking News from Edwards Lifesciences

Cardiologists Couldn't Push a New Heart Valve into Place Until They Lassoed Its Delivery System Like a Cowboy

When standard moves failed to seat a new tricuspid valve, German cardiologists snared its delivery system with a wire loop and guided it home.

Medical Daily · Sep 21

Unusual Volume in Edwards Lifesciences Put Options Shows Investors Bullish on EW Stock

An unusually high volume of out-of-the-money (OTM) put options in Edwards Lifesciences (EW) shows investors are bullish on EW stock over the next three months. Moreover, EW is below analysts' price targets.

Barchart · Aug 31

Is Wall Street Bullish or Bearish on Edwards Lifesciences Stock?

Though Edwards Lifesciences has underperformed the broader market over the past year, Wall Street analysts maintain a strongly optimistic outlook on the stock’s prospects.

Barchart · Aug 12

Edwards Lifesciences Stock: Is Wall Street Bullish or Bearish?

Although Edwards Lifesciences has outpaced the broader market over the past year, analysts remain measured in their expectations, maintaining a cautiously optimistic view as they look for continued execution and sustained growth drivers.

Barchart · Nov 11, 2025

Here's What to Expect From Edwards Lifesciences’ Next Earnings Report

Edwards Lifesciences is all set to release its fiscal third-quarter earnings later this month, and analysts project a double-digit earnings drop.

Barchart · Oct 6, 2025

Edwards Lifesciences Stock: Is EW Outperforming the Healthcare Sector?

As Edwards Lifesciences outshines the broader healthcare sector, Wall Street remains optimistic about its prospects.

Barchart · Sep 2, 2025

Edwards Lifesciences Stock: Analyst Estimates & Ratings

Though Edwards Lifesciences has outperformed the SPX over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.

Barchart · Aug 13, 2025

FTC Sounds Alarm On Edwards' Attempt To Corner Heart Device Market

The Federal Trade Commission (FTC) on Wednesday moved to block medical device supplier Edwards Lifesciences Corp.'s (NYSE:EW) proposed acquisition of JenaValve Technology, Inc.

Benzinga · Aug 8, 2025

Edwards Lifesciences Lifts 2025 Outlook On Strong First Half Performance

Edwards Lifesciences’ (NYSE:EW) stock surged Friday following a strong second-quarter 2025 earnings report that saw the medical device innovator surpass revenue and earnings expectations, driven by significant growth across its heart valve therapies.

Benzinga · Jul 25, 2025

Edwards Lifesciences Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Results

Edwards Lifesciences Corporation (NYSE:EW) reported better-than-expected second-quarter financial results on Thursday.

Benzinga · Jul 25, 2025